Waters and Restek Announce Co-Marketing Agreement
Waters and Restek have entered into a co-marketing agreement aimed at food safety laboratories and promoting the use of Waters gas chromatography–mass spectrometry instruments with Restek GC consumables.
Waters (Milford, Massachusetts, USA) and Restek (Bellefonte, Pennsylvania, USA) have entered into a co-marketing agreement aimed at food safety laboratories and promoting the use of Waters gas chromatography–mass spectrometry instruments with Restek GC consumables.
“We are delighted to enter into this agreement with Restek,” said Jeff Mazzeo, Vice President, Marketing, Waters Corporation. “Like Waters, they are strongly committed to making customers successful, [their] GC consumables and technical support play an important role in helping our customers monitor for pesticides and other contaminants and meet the sensitivity requirements of global regulated methods,” continued Mazzeo.
Under the terms of the agreement, Waters and Restek will work together to provide food safety laboratories with training and applications support of GC–MS methods and workflows for pesticide monitoring and screening.
“Restek is excited to work with Waters on this new venture,” said Rick Lake, Vice President, Marketing, Restek Corporation. “By collaborating, we can combine our unique expertise to help analysts around the world perform the vital job of ensuring the safety of a food supply we all share,” added Lake.
For more information, please visit: www.waters.com/tqgc or www.restek.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
